EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome Sequencing Outperforms Exome Sequencing in Formalin‐Fixed Paraffin Embedded Tumors Leading to Improved Treatment Options

Nadja Ballin, Alexander Ott, Michaela Pogoda, Florian Harmuth, Vijay Kumar Ulaganathan iD, Anton Karelin iD, Cristiana Roggia iD, Irina Bonzheim iD, Stephan Singer, Holly Sundberg-Malek iD, Pavlos Missios, Stephan Ossowski iD und 6 weitere

Cancer Medicine · 2026

DOI: 10.1002/cam4.72448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Nadja Ballin und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Exome Sequencing, Neoplasms, Whole Genome Sequencing. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precision oncology is based on comprehensive molecular characterization of a patient's tumor. This is mostly realized by next‐generation sequencing panels or exome sequencing. Data on the value of genome sequencing from formalin‐fixed paraffin embedded (FFPE) material in a clinical setting is still scarce. In this pilot, we generated datasets of matched exome and genome sequencing of FFPE tumor samples from 15 cancer patients to benchmark quality metrics, clinical feasibility, and added value for a molecular tumor board. Despite the reduced sequencing depth, diagnostic detection of small nucleotide variations, copy number variations, and complex biomarkers was maintained in genome sequencing compared to exome sequencing with the exception of hard‐to‐sequence regions. Evaluation by the local molecular tumor board identified additional treatment recommendations with high priority in 20% (3/15) of patients and additional molecular markers to support existing treatment recommendations in another 20% (3/15) of patients. Our work underscores the diagnostic superiority of genome sequencing even for FFPE samples and therefore supports its integration into clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Exome SequencingNeoplasmsWhole Genome SequencingHumansParaffin EmbeddingFormaldehydeTissue FixationDNA Copy Number VariationsHigh-Throughput Nucleotide SequencingBiomarkers, TumorExomePrecision MedicineShotgun SequencingFemaleGenome, Human

Stichwörter der Autor:innen

FFPEmolecular tumor boardprecision oncologytumor exome sequencingtumor genome sequencing

Substanzen

FormaldehydeBiomarkers, Tumor

Autor:innen und Institutionen

  • Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.
  • NGS Competence Center Tübingen (NCCT), Tübingen, Germany.
  • Department of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.
  • Center for Personalized Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.

ORCID-Profile: Vijay Kumar Ulaganathan, Anton Karelin, Cristiana Roggia, Irina Bonzheim, Holly Sundberg-Malek, Stephan Ossowski, Tobias B Haack, Olaf Riess, Sorin Armeanu-Ebinger

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Ballin, N., Ott, A., Pogoda, M., Harmuth, F., Ulaganathan, V. K., Karelin, A., Roggia, C., Bonzheim, I., Singer, S., Sundberg-Malek, H., Missios, P., Ossowski, S., Haack, T. B., Riess, O., Bitzer, M., Malek, N., Schroeder, C., & Armeanu-Ebinger, S. (2026). Genome Sequencing Outperforms Exome Sequencing in Formalin‐Fixed Paraffin Embedded Tumors Leading to Improved Treatment Options. Cancer Medicine. https://doi.org/10.1002/cam4.72448

Vancouver

Ballin N, Ott A, Pogoda M, Harmuth F, Ulaganathan VK, Karelin A, et al. Genome Sequencing Outperforms Exome Sequencing in Formalin‐Fixed Paraffin Embedded Tumors Leading to Improved Treatment Options. Cancer Medicine. 2026. doi:10.1002/cam4.72448

BibTeX
@article{Ballin2026,
  author = {Ballin, Nadja and Ott, Alexander and Pogoda, Michaela and Harmuth, Florian and Ulaganathan, Vijay Kumar and Karelin, Anton and Roggia, Cristiana and Bonzheim, Irina and Singer, Stephan and Sundberg-Malek, Holly and Missios, Pavlos and Ossowski, Stephan and Haack, Tobias B and Riess, Olaf and Bitzer, Michael and Malek, Nisar and Schroeder, Christopher and Armeanu-Ebinger, Sorin},
  title = {Genome Sequencing Outperforms Exome Sequencing in Formalin‐Fixed Paraffin Embedded Tumors Leading to Improved Treatment Options},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.72448}
}
Kostenlos starten →